Oxytocin Panpharma

Oxytocin, the active ingredient in Oxytocin Panpharma, is a peptide hormone presented as a sterile injectable solution for intramuscular or intravenous use. It is employed to induce uterine contractions during labor and to control postpartum hemorrhage in obstetric care. GNH USA supplies Oxytocin Panpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Oxytocin Panpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Oxytocin is a peptide hormone that acts on the uterine smooth muscle pathway to facilitate childbirth and manage bleeding.

- Induction of labor: Promotes effective uterine contractions to initiate vaginal delivery. - Postpartum hemorrhage control: Enhances uterine tone to reduce excessive bleeding after delivery. - Medical abortion support: Assists in uterine evacuation when used with prostaglandins. - Management of incomplete miscarriage: Facilitates expulsion of retained products of conception. - Induction of labor in cases of cervical ripening failure: Provides an alternative when mechanical methods are insufficient.

Oxytocin may cause a range of adverse reactions, most of which are dose‑dependent and related to its uterine‑stimulating properties.

Common Side Effects: - Nausea: Mild to moderate nausea may occur during infusion. - Headache: Transient headache is reported by some patients. - Uterine hyperstimulation: Excessive uterine contractions can develop if dosing is too rapid. - Flushing: Warmth or flushing of the skin may be experienced. - Hypotension: A drop in blood pressure can occur, especially with rapid IV administration.

Serious or Rare Side Effects: - Uterine rupture: Rare but severe tearing of the uterus, typically in a scarred uterus. - Cardiac arrhythmia: Abnormal heart rhythms may develop with high circulating levels. - Severe hypotension: Marked blood pressure decline requiring medical intervention. - Allergic reaction: Anaphylaxis or severe hypersensitivity to the peptide. - Water intoxication: Hyponatremia from excessive fluid retention during prolonged infusion.

When using Oxytocin, clinicians should observe several safety measures to minimize risks.

- Patient assessment: Evaluate obstetric history and uterine scar status before administration. - Dose titration: Start with the lowest effective dose and adjust gradually based on uterine response. - Monitoring: Continuously monitor fetal heart rate and maternal vital signs during infusion. - Contraindications: Avoid use in cases of placenta previa, vasa previa, or severe pre‑eclampsia. - Storage: Store at 2-8°C: keep refrigerated, protect from light and avoid freezing.

Oxytocin can interact with several medications that influence uterine tone or cardiovascular function.

Major Interactions (Avoid): - Prostaglandin analogues : E       -    -    

g   g \